Trial Profile
Retrospective study investigating incidence of skeletal-related events in patient with breast cancer treated with bisphosphonates or denosumab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jan 2018
Price :
$35
*
At a glance
- Drugs Bisphosphonates (Primary) ; Denosumab (Primary)
- Indications Bone metastases; Breast cancer
- Focus Therapeutic Use
- 12 Jan 2018 New trial record
- 09 Dec 2017 Results presented at the 40th Annual San Antonio Breast Cancer Symposium.